Skip to content
6 physician-led programs. Know your costs before you begin.See what we treat
GLP-1 library · Vayra

The GLP-1 reference, the same standard of care.

Vayra prescribes branded Wegovy®, Zepbound®, and Mounjaro® for chronic weight management, and Ozempic® for patients with type-2 diabetes. Your membership covers physician care and labs; your branded medication is priced separately and shown with the total.

Branded GLP-1

Why our GLP-1 program uses FDA-approved branded medication.

This brand-only stance is specific to GLP-1. Compounded semaglutide and tirzepatide are restricted, and are lawful only when a documented clinical difference cannot be met by an FDA-approved product. Cost, insurance denial, and patient preference are not lawful clinical differences.

For the vast majority of patients, the FDA-approved branded product, Wegovy®, Zepbound®, or Mounjaro® (and Ozempic® where T2D is the indication), is the right standard of care. That is why our GLP-1 program prescribes the branded product rather than compounded semaglutide or tirzepatide. In other Vayra programs, your physician may prescribe an individualized, physician-directed 503A compounded option when it is clinically appropriate, determined at your visit (503A preparations are not FDA-approved).

Your Vayra membership covers your physician care and your labs; your branded medication is priced separately and shown with the total, one integrated program with the same physician from your first visit onward.

Your health info stays private (HIPAA)
Licensed doctors in 40+ states
Filled by a licensed pharmacy
No insurance needed · Use your FSA or HSA

Begin a documented physician visit.

Continuity is a priority, you will see the same physician whenever clinically possible. 45-min initial visit, 30-min monthly check-ins, unlimited secure messaging. Private clinical practice, no insurance billing.